维普中文期刊产品整合服务
40篇 您的检索式:作者名="SE Cross"
    题名 作者 年代 出处 被引量
1Functional characterization of cell-wall-associated protein WapA in Streptococcus mutans 显示文摘IZHU L KRETH J CROSS SE 2006Microbiology2006,152,8:1
2Nanomechanical analysis of cells from cancer patients显示文摘Cross SE Jin YS Rao JY 2008Nature Nanotech2008,2,:1
3Topical penetration of commercial salicylate esters and salts using human isolated skin and clinical microdialysis studies显示文摘CROSS SE ANDERSON C ROBERTS MS 1998Br J Clin Pharmacol1998,46,1:1
4AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer 显示文摘Cross DAE Ashton SE Ghiorghiu S 2014Cancer Dis- cov2014,4,9:1
5Vascular endothelial growth factor as a survival factor for human islets: effect of immunosuppressive drugs 显示文摘Cross SE Richards SK Clark A et el 2007Diabetologia2007,50,7:1
6Effect of vehicle pretreat- ment on the flux, retention, and diffusion of topically applied penetrants in vitro显示文摘Rosado C Cross SE Pugh WJ 2003Pharm Res2003,20,9:1
7Nanomechanical analysisof cells from cancer patients显示文摘Cross SE Jin YS Rao J 2007Nat Nanotechnol2007,2,12:1
8A physiological pharmacokinetic model for solute disposition in tissues below a topical application site显示文摘Roberts MS Cross SE 1999Pharm Res1999,16,9:1
9Nanomechanical analysis ofcells from cancer patients显示文摘Cross SE Jin YS Rao J 2007Nat Nanotechnol2007,2,12:1
10Physical enhancement of transdermal drug application:is delivery technology keeping up with pharmaceutical development?显示文摘Cross SE Roberts MS 2004Curr Drug Deliv2004,1,1:1
11Physical enhancement of transdermal drug application:is delivery technology keeping up with pharmaceutical development显示文摘Cross SE Roberts MS 0,,01:1
12Nanomechanical analysis of cells from cancer patients 显示文摘Cross SE Jin YS Rao J 2007Nat Nanotechnol2007,2,12:1
13Functional characterization of cell- wall-associated protein WapA in Streptococcus mutans 显示文摘Zhu L Kreth J Cross SE 2006Microbiol2006,152,8:1
14Functional characterization of cellwallassociated protein WapA in Strepto- coccus mutans显示文摘Zhu L Kreth J Cross SE 2006Microbiology2006,1528,:1
15Physical enhancement of transdermal drug application:is delivery technology keeping up with pharmaceutical development显示文摘Cross SE Roberts MS 2004Current Drug Deliv2004,11,4:1
16Physical enhancement of transdermal drug application: Is delivery technology keeping up with pharmaceutical development?显示文摘SE Cross MS Roberts 2004Current Drug Delivery2004,1,:1
17Long- Acting Dihydropyriding Calcium Antagonista, 1, 2 - Alkoxymethel Derivatves Inoorporating Basic Substitues 显示文摘Arrowsmith JE Campbell SE Cross PE 1986J Med Chem1986,29,9:1
18Effect of vehicle pretreatment on the flux,retention,and diffusion of topically applied penetrants in vitro显示文摘Rosado C Cross SE Pugh WJ 2003Pharm Res2003,20,9:1
19Collagenase penetrates human pancreatic islets following standard intraductal administration显示文摘Cross SE Hughes S J Partridge C J 2008Transplantation2008,86,:1
20AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer显示文摘CROSS DA ASHTON SE GHIORGHIU S et 01 2014Cancer Discov2014,4,9:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费